 |
市場調查報告書
商品編碼
1907952
組織分散市場：按產品、應用、最終用戶、技術和地區分類Tissue Dissociation Market, By Product, By Application, By End User, By Technology, By Geography |
||||||
組織權力下放市場預計在 2025 年達到 3.559 億美元，預計到 2032 年將達到 6.381 億美元，2025 年至 2032 年的複合年成長率 (CAGR) 為 8.7%。
| 分析範圍 | 分析詳情 | ||
|---|---|---|---|
| 基準年 | 2024 | 市場規模（2025 年） | 3.559億美元 |
| 效能數據 | 2020-2024 | 預測期 | 2025-2032 |
| 預測期（2025-2032 年）複合年成長率 | 8.70% | 預計金額（2032 年） | 6.381億美元 |
全球組織解離市場是生命科學和生物技術產業的關鍵細分市場，涵蓋了將生物組織系統性地解離成單一細胞的各種技術，可用於多種研究和臨床應用。這個複雜的過程利用專用酵素、機械裝置和自動化系統，在維持細胞活力和功能的同時，將複雜的組織結構分離成單細胞懸浮液。組織解離是眾多下游應用的基礎前提，包括細胞培養、流式細胞技術分析、單細胞定序、藥物研發、再生醫學和癌症研究。
該市場涵蓋多種產品，包括酶解試劑盒、機械解離器、自動化組織解離器以及針對特定組織類型（例如腫瘤組織、神經組織、脂肪組織和胚胎組織）設計的專用試劑。人們對個人化醫療日益成長的興趣、細胞療法的進步以及單細胞分析技術在藥物研發中的廣泛應用，正推動著該市場的顯著成長。此外，慢性病的日益增加以及由此帶來的對先進診斷和治療方法的需求，也進一步推動了全球學術研究機構、製藥公司、生物技術公司和臨床檢查室對該市場的擴張。
市場動態
全球組織解離市場主要由以下幾個關鍵因素驅動，這些因素正在改變生物學研究和臨床應用的模式。細胞研究和開發的指數級成長，尤其是在癌症免疫療法、幹細胞研究和再生醫學等領域，催生了對高效組織解離解決方案的空前需求。單細胞分析技術（包括單細胞RNA定序和流式細胞技術）的日益普及，需要高品質的細胞懸浮液，而這只有透過先進的組織解離技術才能實現，從而推動了市場成長。此外，藥物研發投入的增加以及針對細胞療法的臨床試驗數量的成長，也顯著推動了市場需求。
然而，市場存在一些限制：自動化解離系統和專用試劑的高成本可能會阻礙預算緊張的小規模研究機構和實驗室採用這些系統，而解離過程中保持細胞活力的技術挑戰，特別是對於脆弱的細胞類型，會給最終用戶帶來操作上的困難。
此外，不同組織類型和研究應用缺乏標準化的通訊協定，可能導致結果差異，從而阻礙市場成長。儘管存在這些挑戰，自動化技術的進步以及能夠保持細胞完整性的更溫和的分離方法的開發，為市場提供了巨大的成長機會。在類器官研究、組織工程和3D細胞培養模型等新興領域的應用拓展，也蘊藏著巨大的成長潛力。此外，對組織特異性分離試劑盒研發的日益重視，以及亞太和拉丁美洲等新興市場需求的成長，也為市場擴張和創新提供了豐厚的機會。
本報告的主要特點
- 本報告對全球組織權力下放市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和復合年成長率。
- 它還重點介紹了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
- 它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的關鍵見解。
- 全球組織分權市場的主要企業已根據以下參數進行了概況介紹，例如公司概況、產品系列、主要亮點、財務表現和策略。
- 本報告提供的見解將使負責人和公司經營團隊能夠就未來的產品發布、產品更新、市場擴張和行銷策略做出明智的決策。
- 《全球組織分權市場》報告面向該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
- 相關人員可以透過各種用於分析全球組織分銷市場的策略矩陣，更輕鬆地做出決策。
目錄
第1章 分析目標與先決條件
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章：市場動態、監理及趨勢分析
- 市場動態
- 促進要素
- 抑制因素
- 機會
- 影響分析
- 重大進展
- 監管情景
- 產品上市/核准
- PEST分析
- 波特五力分析
- 企業合併情景
- 產業趨勢
第4章 全球組織分權市場（依產品分類）（2021-2033 年）
- 酵素和試劑盒
- 裝置
- 耗材和配件
第5章 全球組織分權市場依應用領域分類（2021-2033 年）
- 細胞分離
- 藥物發現與開發
- 組織工程
- 尿道感染（UTI）
- 幹細胞研究
- 癌症研究
- 其他生物醫學應用
6. 全球組織分散劑市場（依劑型分類）（2021-2033 年）
- 腸外
- 口服
- 外用
7. 全球組織去中心化市場（依最終使用者分類）（2021-2033 年）
- 製藥和生物技術公司
- 學術和研究機構
- 醫院和診斷檢查室
- CRO（委外研發機構）
8. 全球組織分散化市場（依技術分類）（2021-2033 年）
- 手動組織分散
- 自動組織分散
9. 全球組織權力下放市場（按地區分類）（2021-2033 年）
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太地區
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
- 非洲
- 南非
- 北非
- 中非
第10章 競爭格局
- Thermo Fisher Scientific
- Merck KGaA
- Danaher Corporation
- STEMCELL Technologies
- Sartorius AG
- Becton Dickinson Biosciences
- Miltenyi Biotec
- PAN-Biotech
- HiMedia Laboratories
- Hoffmann-La Roche Ltd
- S2 Genomics, Inc.
- Worthington Biochemical Corporation
- Sigma-Aldrich Corporation
- VitaCyte LLC
- Innovative Cell Technologies, Inc.
第11章 分析師建議
- 機會
- 分析師觀點
- Coherent Opportunity Map (COM)
第12章 參考文獻與分析方法
- 參考
- 分析方法
- 關於 Coherent Market Insights
Tissue Dissociation Market is estimated to be valued at USD 355.9 Mn in 2025 and is expected to reach USD 638.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.7% 2025 To 2033 from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 355.9 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2033 |
| Forecast Period 2025 to 2032 CAGR: | 8.70% | 2032 Value Projection: | USD 638.1 Mn |
The global tissue dissociation market represents a critical segment within the life sciences and biotechnology industry, encompassing the systematic breakdown of biological tissues into individual cells for various research and clinical applications. This sophisticated process involves the use of specialized enzymes, mechanical devices, and automated systems to separate complex tissue structures into single-cell suspensions while maintaining cellular viability and functionality. Tissue dissociation serves as a fundamental prerequisite for numerous downstream applications including cell culture, flow cytometry analysis, single-cell sequencing, drug discovery, regenerative medicine, and cancer research.
The market encompasses a diverse range of products including enzymatic dissociation kits, mechanical dissociation instruments, automated tissue dissociators, and specialized reagents designed for specific tissue types such as tumor tissues, neural tissues, adipose tissues, and embryonic tissues. The growing emphasis on personalized medicine, advancement in cell-based therapies, and increasing adoption of single-cell analysis techniques in pharmaceutical research are driving substantial growth in this market. Additionally, the rising prevalence of chronic diseases and the corresponding need for advanced diagnostic and therapeutic approaches are further propelling market expansion across academic research institutions, pharmaceutical companies, biotechnology firms, and clinical laboratories worldwide.
Market Dynamics
The global tissue dissociation market is primarily driven by several key factors that are reshaping the landscape of biological research and clinical applications. The exponential growth in cell-based research and therapy development, particularly in areas such as cancer immunotherapy, stem cell research, and regenerative medicine, is creating unprecedented demand for efficient tissue dissociation solutions. The increasing adoption of single-cell analysis technologies, including single-cell RNA sequencing and flow cytometry, requires high-quality cell suspensions that can only be achieved through advanced tissue dissociation methods, thereby driving market growth. Furthermore, the rising investment in pharmaceutical R&D, coupled with the growing number of clinical trials focusing on cell-based therapies, is significantly boosting market demand.
However, the market faces certain restraints including the high cost of automated dissociation systems and specialized reagents, which can limit adoption among smaller research institutions and laboratories with budget constraints. Technical challenges associated with maintaining cell viability during the dissociation process, particularly for sensitive cell types, also pose operational difficulties for end-users.
Additionally, the lack of standardized protocols across different tissue types and research applications creates inconsistencies in results, potentially hindering market growth. Despite these challenges, the market presents substantial opportunities driven by technological advancements in automation and the development of gentler dissociation methods that preserve cellular integrity. The expanding applications in emerging fields such as organoid research, tissue engineering, and 3D cell culture models offer significant growth potential. Moreover, the increasing focus on developing tissue-specific dissociation kits and the growing demand from emerging markets in Asia Pacific and Latin America present lucrative opportunities for market expansion and innovation.
Key Features of the Study
- This report provides in-depth analysis of the global tissue dissociation market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global tissue dissociation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific, Merck KGaA, Danaher Corporation, STEMCELL Technologies, Sartorius AG, Becton Dickinson Biosciences, Miltenyi Biotec, PAN-Biotech, HiMedia Laboratories, F. Hoffmann-La Roche Ltd, S2 Genomics, Inc., Worthington Biochemical Corporation, Sigma-Aldrich Corporation, VitaCyte LLC, and Innovative Cell Technologies, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global tissue dissociation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global tissue dissociation market
Market Segmentation
- Product Insights (Revenue, USD Mn, 2025 - 2033)
- Enzymes and Kits
- Collagenases
- Trypsin
- Elastases
- Papain
- Hyaluronidase
- Other Enzyme Blends and Kits
- Instruments
- Mechanical Dissociators
- Enzymatic Dissociators
- Ultrasound Dissociators
- Other Instruments
- Consumables and Accessories
- Filters and Strainers
- Dissociation Vessels and Tubes
- Other Disposable Accessories
- Application Insights (Revenue, USD Mn, 2025 - 2033)
- Cell Isolation
- Drug Discovery and Development
- Tissue Engineering
- Stem Cell Research
- Cancer Research
- Other Biomedical Applications
- Dosage Form Insights (Revenue, USD Mn, 2025 - 2033)
- Parenteral
- Oral
- Topical
- End User Insights (Revenue, USD Mn, 2025 - 2033)
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Hospitals and Diagnostic Laboratories
- Contract Research Organizations (CROs)
- Technology Insights (Revenue, USD Mn, 2025 - 2033)
- Manual Tissue Dissociation
- Automated Tissue Dissociation
- Regional Insights (Revenue, USD Mn, 2025 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Thermo Fisher Scientific
- Merck KGaA
- Danaher Corporation
- STEMCELL Technologies
- Sartorius AG
- Becton Dickinson Biosciences
- Miltenyi Biotec
- PAN-Biotech
- HiMedia Laboratories
- Hoffmann-La Roche Ltd
- S2 Genomics, Inc.
- Worthington Biochemical Corporation
- Sigma-Aldrich Corporation
- VitaCyte LLC
- Innovative Cell Technologies, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Tissue Dissociation Market, By Product
- Global Tissue Dissociation Market, By Application
- Global Tissue Dissociation Market, By Dosage Form
- Global Tissue Dissociation Market, By End User
- Global Tissue Dissociation Market, By Technology
- Global Tissue Dissociation Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Tissue Dissociation Market, By Product, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Enzymes and Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Collagenases
- Trypsin
- Elastases
- Papain
- Hyaluronidase
- Other Enzyme Blends and Kits
- Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Mechanical Dissociators
- Enzymatic Dissociators
- Ultrasound Dissociators
- Other Instruments
- Consumables and Accessories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Filters and Strainers
- Dissociation Vessels and Tubes
- Other Disposable Accessories
5. Global Tissue Dissociation Market, By Application, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Cell Isolation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Drug Discovery and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Tissue Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Urinary Tract Infections (UTIs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Stem Cell Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Cancer Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Other Biomedical Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Tissue Dissociation Market, By Dosage Form, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Tissue Dissociation Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Hospitals and Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Tissue Dissociation Market, By Technology, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Manual Tissue Dissociation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Automated Tissue Dissociation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
9. Global Tissue Dissociation Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- STEMCELL Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sartorius AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton Dickinson Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Miltenyi Biotec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PAN-Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- HiMedia Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- S2 Genomics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Worthington Biochemical Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sigma-Aldrich Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- VitaCyte LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Innovative Cell Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
